Gudnes Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-06-2024
- Paid Up Capital ₹ 0.30 M
as on 21-06-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 M
as on 21-06-2024
- Revenue 104.94%
(FY 2022)
- Profit 28.87%
(FY 2022)
- Ebitda 10.17%
(FY 2022)
- Net Worth 88.28%
(FY 2022)
- Total Assets 51.46%
(FY 2022)
About Gudnes Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.20 M.
Rajshekhar Doddabasannavar and Geeta Doddabasannanavar serve as directors at the Company.
- CIN/LLPIN
U24239KA2017PTC103372
- Company No.
103372
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 2017
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Gudnes Healthcare Private Limited offer?
Gudnes Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Antihistamines, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Anti Infective Drugs & Medicines, Antibacterial Drugs, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Gudnes Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajshekhar Doddabasannavar  | Director | 26-May-2017 | Current |
| Geeta Doddabasannanavar | Director | 26-May-2017 | Current |
Financial Performance of Gudnes Healthcare.
Gudnes Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 104.94% increase. The company also saw a substantial improvement in profitability, with a 28.87% increase in profit. The company's net worth Soared by an impressive increase of 88.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gudnes Healthcare?
In 2020, Gudnes Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Macto Mediscience Private LimitedActive 15 years 3 monthsRajshekhar Doddabasannavar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 May 2023 | ₹1.20 M | Open |
How Many Employees Work at Gudnes Healthcare?
Gudnes Healthcare has a workforce of 12 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gudnes Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gudnes Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
